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It has been traditionally suggested that polymorphism of cocrystals is a 35 
phenomenon seen less frequently than in monocomponent crystals. However, since the 36 
research on cocrystals has recently experienced a big growth, the number of solved 37 
structures of polymorphic cocrystals in the Cambridge Structural Database has increased, 38 
which can help to understand better whether a lower impact of this phenomenon exists or 39 
not in multicomponent crystals. In this paper we describe the cocrystal landscape of 40 
agomelatine, a particularly promiscuous drug able to cocrystallize with up to nine different 41 
coformers. Interestingly, two of those coformers have produced polymorphic cocrystals 42 
during the screening, which converts agomelatine into a new example that questions the 43 
traditional belief of the lesser impact of polymorphism in cocrystals and highlights the 44 
importance of polymorphism studies in cocrystal screening. Our work is completed with 45 
the determination of the crystal structures of the new forms from combined single crystal/ 46 









1. INTRODUCTION 56 
 57 
Polymorphism of active principle ingredients (API) is almost omnipresent.1 In fact, published data from 58 
experimental screens suggest that 80−90% of organic compounds can exist in multiple crystalline forms 59 
(polymorphs and solvates) and half of the organic compounds can be polymorphic.2 In recent years, the 60 
number of new crystal forms for a drug has been much increased since the erruption of cocrystals in the 61 
solid state arena, which offers many opportunities to modify their bulk properties, such as solubility, 62 
bioavailability and stability. According to Butterhof et al.,3 the number of characterized polymorphs and 63 
cocrystals in 2012 was 2050 and 3650, respectively. In 2010 Zaworotko et al.4 analyzed 38 polymorphic 64 
cocrystals, revealing that in 35 polymorphic pairs polymorphism is the result of conformational 65 
flexibility and/or structural changes in the packing. 66 
Moreover, an exhaustive search in the literature by Aitipamula et al. in 20135 revealed a total of 110 67 
neutral polymorphic cocrystals. The lower propensity of cocrystals to exhibit polymorphism has been 68 
then called into question, and probably a bigger corpus of crystallographic data will be required before 69 
the question can be reliably answered.6 Since multicomponent crystals are increasingly relevant in the 70 
pharmaceutical industry with cocrystal screenings being routinely performed, a better understanding of 71 
polymorphism of cocrystals is a real need. In this paper we intend to contribute new data in order to 72 
enrich this relevant debate. Agomelatine (N-[2-(7-methoxynaphthalen-1-yl)ethyl]-acetamide) (Figure 1), 73 
under the trade name of Valdoxan or Melitor, is an effective drug for the treatment of major depressive 74 
disorders7 first produced by Servier pharmaceutical company in 2009. It has been reported to exist as 75 
six polymorphic modifications (Forms I−VI). The crystal structures of Forms I, II, and III have been 76 
determined8,9 by single and powder X-ray diffraction, and cocrystals with acetic acid, ethylene glycol, 77 
urea, glycolic acid, isonicotinamide, and methyl 4-hydroxybenzoate have been synthesized and 78 
structurally characterized.9,10 79 
The pharmaceutical relevance of this compound together with the existence of a big number of different 80 
multicomponent crystal modifications prompted us to study its cocrystal promiscuity in relation with the 81 
presence of polymorphism. In this contribution, we take a step forward in the investigation of the solid-82 
state landscape of agomelatine by presenting new polymorphic cocrystals with acetic acid and 83 
hydroquinone, together with cocrystals with pyruvic acid and oxalic acid. 84 
.85 
2. MATERIALS AND METHODS 86 
 87 
2.1. Synthesis of the New Crystal Forms. 2.1.1. Hydroquinone Cocrystal Ago-HQ Form I. 100 88 
milligrams (0.41 mmol) of agomelatine and 45 mg (0.41 mmol) of hydroquinone were dissolved in 0.1 89 
mL of acetone or ethyl acetate. Crystals suitable for single crystal X-ray diffraction (SCXRD) were 90 
obtained after evaporation of the solvent at room temperature after 2 days (mp 81 °C). 91 
 92 
2.1.2. Hydroquinone Cocrystal Ago-HQ Form II. Twenty milligrams (0.08 mmol) of agomelatine and 93 
10 mg (0.09 mmol) of hydroquinone were grinded in a ball mill with the addition of one drop of 94 
acetonitrile during 30 min at 30 Hz (mp 93 °C). 95 
 96 
2.1.3. Oxalic Acid Cocrystal Ago-OA Form I. Twenty milligrams (0.08 mmol) of agomelatine and 7 mg 97 
(0.08 mmol) of oxalic acid were dissolved in 50 μL of isopropanol at 40 °C, and the solution was cooled 98 
to room temperature in a closed vial. Crystals suitable for SCXRD were obtained after 1 day (mp 87°C). 99 
 100 
2.1.4. Acetic Acid Cocrystal Ago-AA Form II. 80 milligrams (0.33 mmol) of agomelatine were 101 
dissolved in 50 μL of acetic acid at 45 °C, and the solution was cooled to room temperature in a closed 102 
vial. Crystals suitable for SCXRD were obtained after 20 days (mp 65 °C).  103 
 104 
2.1.5. Pyruvic Acid Cocrystal Ago-PA. 200 milligrams (0.82 mmol) of agomelatine were dissolved in 105 
0.5 mL of pyruvic acid at 50 °C. The solution was cooled to 5 °C in a closed vial, and crystals suitable 106 
for SCXRD were obtained after 5 days (mp 69 °C). 107 
 108 
2.2. Methods. 2.2.1. Powder X-ray Diffraction (PXRD). Powder Xray diffraction patterns were obtained 109 
on a PANalytical X’Pert PRO MPD diffractometer in transmission configuration using Cu Kα1 + 2 110 
radiation (λ = 1.5418 Å) with a focalizing elliptic mirror and a PIXcel detector working at a maximum 111 
detector’s active length of 3.347°. Capillary geometry has been used with samples placed in glass 112 
capillaries (Lindemman) of 0.5 mm of diameter measuring from 2 to 60° in 2θ, with a step size of 113 
0.026° and a total measuring time of 30 min. Flat geometry has been used for routine samples 114 
sandwiched between low absorbing films (polyester of 3.6 μm of thickness) measuring 2theta/theta 115 
scans from 2 to 40° in 2θ with a step size of 0.026° and a measuring time of 76 s per step. The PXRD 116 
pattern of hydroquinone cocrystal was obtained using synchrotron radiation at ALBA’s beamline BL04-117 
MSPD using Mythen detector. The wavelength, 0.6196 Å, was selected with a double-crystal Si (111) 118 
monochromator and determined from a Si640d NIST standard (a = 5.43123 Å) measurement. The 119 
diffractometer is equipped with a socalled MYTHEN detector system especially suited for time-resolved 120 
experiments. The capillary of 0.7 mm containing the sample was rotated during data collection to 121 
improve diffracting particle statistics. The data acquisition time was 10 min per pattern, and the final 122 
treated data are the addition of 10 acquisitions to attain a very good signal-tonoise ratio over the angular 123 
range 0.5−43.6° (2θ) at 100 K. 124 
 125 
2.2.2. Single Crystal X-ray Diffraction. Ago-AA Form II. MAR345 diffractometer with an image plate 126 
detector was used. Intensity data were collected with graphite monochromatized MoKα radiation (λ = 127 
0.71073 Å) using a ϕ-scan technique. The structures were solved by direct methods, using the SHELXS 128 
computer program, and refined by full-matrix least-squares method with the SHELX97 computer 129 
program. Ago-HQ Form I, Ago-OA Form I and Ago-PA. A D8 Venture system equipped with a 130 
Multilayer monochromator and a Mo microfocus (λ = 1.54178 Å) was used. The structures were solved 131 
using the Bruker SHELXTL Software Package and refined using SHELXL.11 132 
 133 
2.2.3. Differential Scanning Calorimetry (DSC). Differential scanning calorimetry was carried out by 134 
means of a Mettler-Toledo DSC-822e calorimeter. Experimental conditions: aluminum crucibles of 40 135 
μL volume, atmosphere of dry nitrogen with 50 mL/min flow rate, and heating rate of 10 °C/min. The 136 
calorimeter was calibrated with indium of 99.99% purity. All the melting points reported have been 137 
measured under these conditions. 138 
 139 
2.2.4. Thermogravimetric Analysis (TGA). Thermogravimetric analyses were performed with all solids 140 
obtained during the screening to detect the presence of solvates on a Mettler-Toledo TGA-851e 141 
thermobalance. Experimental conditions: alumina crucibles of 70 μL volume, atmosphere of dry 142 
nitrogen with 50 mL/min flow rate, and heating rate of 10 °C/min. 143 
 144 
2.2.5. Miller. Liquid-assisted grinding experiments were performed with a Retsch ball mill MM 2000 145 
equipped with two metal vessels, each with four 2 mL cavities. Two tungsten balls (diameter 3 mm) 146 




3. RESULTS AND DISCUSSION 151 
 152 
3.1. Bibliographic Search. Recently, a search of polymorphic cocrystals that contain at least two 153 
neutral organic solid components under ambient conditions has been reported showing 110 systems.5 154 
We have updated this information by analyzing the Cambridge Structural Database (CSD, November 155 
2014), and we have found 128 polymorphic cocrystals (Refcodes included in Supporting Information 156 
(SI)), involving 165 different compounds. Among them, 41 compounds (a list can be found in SI) appear 157 
in more than one system. These data suggest that it is quite likely from a statistical point of view that 158 
compounds forming polymorphic cocrystals with one coformer will do the same with other coformers. 159 
This tendency is observed in the case of agomelatine as we report in the present study two polymorphic 160 
cocrystals with acetic acid and hydroquinone. 161 
3.2. Cocrystal Screening. Agomelatine contains a secondary amide group which can be involved in 162 
supramolecular heterosynthons with different complementary functional groups such as carboxylic 163 
acids, alcohols, esters, amides, etc. as it has been demonstrated by the cocrystals previously 164 
reported.9,10 Therefore, based on this information, we have investigated a number of coformers (see 165 
SI). After performing drop grinding experiments with equimolar amounts of agomelatine and each 166 
coformer, the previously described cocrystals in the literature were detected together with new 167 
cocrystals with hydroquinone, acetic acid, pyruvic acid, and oxalic acid. 168 
Results of liquid-assisted grinding experiments between agomelatine and hydroquinone and oxalic acid 169 
with one drop of four different solvents (water, acetonitrile, ethyl acetate, and cyclohexane) are shown in 170 
Table 1. As it can be seen, two different cocrystals for each coformer were obtained depending on the 171 
solvent used in liquid-assisted grinding experiments. It has been previously reported that liquid-assisted 172 
grinding methodology can provide a successful means of controlling the polymorphic outcome of 173 
cocrystallization. For example, in the case of caffeine and glutaric acid, the addition of some drops of a 174 
nonpolar solvent (such as n-hexane, cyclohexane, or heptane) to equimolar quantities of caffeine and 175 
glutaric acid resulted in cocrystal form I. Conversely, the addition of some drops of a more polar 176 
solvent, including chloroform, dichloromethane, acetonitrile, and water, yielded cocrystal form II with 177 
identical secondary architecture.12 A similar observation has been reported for the polymorphic 178 
cocrystals of caffeine and anthranilic acid (both polymorphs exhibit the same synthon) where the dipole 179 
moment and the functional group of the solvent seemed to play a role, and only if the solvent molecule 180 
had a high dipole moment, was cocrystal form II formed, nitromethane being an exception despite its 181 
high dipole moment.13 Another example shows a high degree of solvent polarity specificity for the 182 
grinding experiments between 5-fluorouracil and 4-hydroxybenzoic acid.14 In the case of the new 183 
agomelatine cocrystals the solvent also plays a major role in the solid form outcome of grinding 184 
experiments with hydroquinone, but it is rather irrelevant with oxalic acid. However, a correlation 185 
between the polarity of the solvent and the solid form obtained is not clear, showing that the 186 
cocrystallization kinetic landscape of a compound can be a very complex issue influenced by many 187 
factors. Regarding the oxalic acid cocrystals, Form II of the Ago-OA cocrystal was always obtained as a 188 
mixture with Form I, and attempts to obtain it by using other methodologies such as slurries or 189 
crystallizations were unsuccessful, so it has not been further studied. 190 
The relative stability between both polymorphs of the hydroquinone cocrystal has been determined. 191 
Suspensions of an equimolar mixture of Ago-HQ Form I and Form II in diisopropylether or toluene 192 
transformed into pure Form II after 3 days, showing that Form I is metastable at room temperature. 193 
Moreover, DSC analysis of Form I shows its melting at 81 °C with simultaneous crystallization of Form 194 
II which melts at 93 °C, suggesting that both polymorphs are monotropically related since the highest 195 
melting form is the most stable one at room temperature (Figure 2).16 196 
Regarding acetic acid and pyruvic acid coformers, which unlike hydroquinone and oxalic acid are 197 
liquids at room temperature, grinding experiments between agomelatine and one drop of each coformer 198 
were performed. A new acetic acid cocrystal different from the previously reported9 and a mixture of 199 
Agomelatine Form II and pyruvic acid cocrystal were obtained, respectively. Both cocrystals were also 200 
obtained by slow crystallization from a solution of agomelatine in either acetic acid or pyruvic acid. 201 
3.3. Crystal Structures Analysis. 3.3.1. Hydroquinone Polymorphic Cocrystals. Two polymorphs of 202 
the hydroquinone cocrystal with 1:1 stoichiometry were obtained. Form I was solved by single crystal 203 
XRD. However, attempts to grow quality crystals of Form II were unsuccessful. Thus, the resolution of 204 
its crystal structure was achieved by using the direct space methodology. 205 
The structure has been determined using synchrotron X-ray powder diffraction data obtained in the high-206 
resolution powder diffraction end station of the MSPD beamline in Alba. The right data have been 207 
obtained with the sample in a 0.7 glass capillary, at 100 K, with a wavelength of 0.6194 Å using the 208 
Mythen detector. Attempts to index high resolution powder diffraction data with Cu Kα laboratory X-209 
ray powder diffraction data at room temperature has not been successful. The 100 K synchrotron powder 210 
diffraction data was perfectly indexed to an orthorhombic cell of about 1830 Å3 by means of 211 
Dicvol04,17 and the space group was perfectly determined to be P212121 from the systematic absences. 212 
The asymmetric unit being one molecule (1:1 agomelatine/hydroquinone stoichiometry), Z = 4, the 213 
crystal structure was determined by direct space methodologies starting from a molecular model 214 
optimized with the commercial software SPARTAN by means of the program FOX18 with the parallel 215 
tempering algorithm. Some constraints were introduced to FOX, considering aromatic rings as rigid 216 
groups. Several trials of 20 million runs were performed. The refinement of the structure has been 217 
performed by the Rietveld method using FullProf.19 Rwp = 3.54%, Chi2 = 80 (compared to Le Bail fit: 218 
Rwp = 2.24%, Chi2 = 32) Figure 3 depicts the final Rietveld plot. 219 
Synthon polymorphism occurs when the primary synthons in the forms are different20 as it is the 220 
present case of the two polymorphs of the agomelatine−hydroquinone cocrystal.  221 
In Form I, hydroquinone molecules form chains in a cis conformation, with the hydroxyl groups of each 222 
molecule acting simultaneously as H-bond acceptor and donor. Layers of agomelatine molecules are 223 
intercalated between the hydroquinone chains stabilized through H-bonds involving both CO and NH 224 
groups of each molecule of agomelatine. 225 
On the other hand, in Form II only the carbonylic oxygen of each agomelatine is involved in a hydrogen 226 
bond with hydroquinone (Figure 4). 227 
Interestingly, the agomelatine molecules do not interact with other agomelatine molecules in the usual 228 
amide/amide selfassembling motif observed in the three agomelatine polymorphs (Refcodes: 229 
WERNOW,8 WERNOW01,9 and WERNOW029). In Form II, again hydroquinone molecules adopt the 230 
cis conformation forming similar self-assembling chains as in Form I, but the most relevant difference 231 
with respect to Form I is that a NH···π interaction is established between the agomelatine amidic proton 232 
and the hydroquinone aromatic ring (NH···centroid distance of 2.58 Å). Moreover, the naphthalene 233 
moieties of agomelatine establish two CH···π interactions (CH···centroid distances of 2.53 and 2.83 Å), 234 
Figure 5. 235 
The hydrogen bonding interaction between the amide group and the aromatic ring is less frequent in 236 
crystal structure of proteins, where the amide/amide is much more predominant, the NH···π interaction 237 
in proteins being first reported by Perutz in 1986.21 However, ab initio calculations revealed that the 238 
NH···π interaction, although weaker than a conventional hydrogen bond, is still significant (up to 3.5 239 
kcal/mol,22 so as Hunter suggested “H-bonding to the face of aromatic rings may play a significant role 240 
in molecular recognition phenomena in different environments”),23 as it has been demonstrated in Form 241 
II, where the strong amide/amide interaction is not observed, while CH···π and NH···π interactions are 242 
relevant. 243 
Another remarkable difference between both polymorphs is the different orientation of the self-244 
assembled hydroquinone chains. While in Form I chains are almost perpendicular, in Form II they are 245 
parallel (Figure 6). Moreover, while in the chains of Form II the hydroquinone molecules are coplanar, 246 
in those of Form I hydroquinone molecules show some displacement from coplanarity. Interestingly, in 247 
both polymorphs, the hydroquinone molecules adopt the cis configuration, which is unusual according 248 
to the reported search in the CSD in which the 87.5% of the 137 analyzed containing hydroquinone 249 
structures were in the trans configuration.24 The absence of inversion centers in both crystal structures 250 
can explain the cis configuration observed in the hydroquinone molecule of both polymorphs and give 251 
additional support to the hypothesis by Pidcock et al.25 in the sense that the molecules with inversion 252 
centers tend to preserve it mainly in centrosymmetric crystal structures.  253 
3.3.2. Pyruvic Acid Cocrystal. The pyruvic acid cocrystal was also solved by single crystal XRD. The 254 
structure of the pyruvic acid cocrystal shows a hydrogen-bond interaction pattern following the expected 255 
hierarchical order between the best donor and the best acceptor of both agomelatine and pyruvic acid, 256 
forming ribbons with an alternate amide/acid supramolecular synthon. Moreover, the pyruvic acid cis 257 
conformation allows the two carbonylic oxygens to point toward the NH proton in an equidistant way 258 
(NH···OC distance of 2.32 Å) (Figure 7). 259 
Interestingly, the crystal structure can be described as hydrogen-bonded aggregates of self-assembled 260 
units formed by two agomelatine and two pyruvic acid molecules. The most remarkable issue of these 261 
units is that they are kept together by the combination of two different kind of interactions: classical 262 
amide/carboxylic acid hydrogen bond together with the less frequent π···π interaction between the 263 
naphthalene rings and the carbonyl groups of pyruvic acid. It has been previously demonstrated through 264 
ab initio quantum mechanical calculations26 that parallel CO/aromatic ring interactions are favorable 265 
with centroid-oxygen distances of around 3.0−3.5 Å. Although in the pyruvic acid cocrystal these 266 
distances are slightly longer (3.58 and 3.67 Å, Figure 8) the almost perfect parallel stacking confirms 267 
this aromatic interaction observed, to some extent, in the crystal structure of proteins. 268 
3.3.3. Acetic Acid Polymorphic Cocrystals. A new polymorph of the acetic acid cocrystal with 1:1 269 
stoichiometry has been obtained. Form I had been previously described in the literature,9 and Form II 270 
was solved by single crystal XRD. Both polymorphs show the same hydrogen-bond interactions 271 
following the expected hierarchical order between the best donor and the best acceptor of both 272 
agomelatine and acetic acid. However, while in Form I the amide and carboxylic acid groups form right-273 
hand cooperative helices through the alternation of NH···O and OH···O hydrogen bonds, in Form II the 274 
same interaction is topologically structured in ribbons (Figure 9). Helixes of Form I are interconnected 275 
through CH···π interactions (CH···centroid distance of 2.97 Å) in an alternated zigzag arrangement of 276 
agomelatine molecules, while layers in Form II are connected through CH···π interactions 277 
(CH···centroid distance of 2.68 Å) between the acetic acid methyl group and the aromatic face of 278 
agomelatine (Figure 10). 279 
Moreover, in Form II the parallel CO/aromatic ring interaction is also observed with a 280 
centroid−oxygen distance of 3.56 Å. 281 
3.3.4. Oxalic Acid Cocrystals. A new oxalic acid cocrystal has been identified during the screening. Its 282 
crystal structure solved by means of single crystal XRD shows a 2:1 stoichiometry. The analysis of the 283 
structure reveals that oxalic acid displays a conformation with both carboxylic groups in a perpendicular 284 
fashion with a 2-fold axis passing through the center of the molecule, which enables four molecules of 285 
agomelatine to surround it, resembling a calix and establishing strong hydrogen-bonding interactions 286 
(Figure 11). 287 
This supramolecular aggregate is repeated thanks to the dual donor/acceptor ability of the amide group, 288 
which forms ribbons of alternate acid/amide interacting groups (Figure 12). Again and in a similar way 289 
as in the cocrystal with hydroquinone, the naphthalene moieties of agomelatine establish two longer 290 
CH···π interactions (CH···centroid distances of 2.89 and 3.24 Å). 291 
3.3.5. Hydrogen Bonding Synthons of Agomelatine Cocrystals. Yan et al.10 in their paper about 292 
agomelatine cocrystals in 2012 presented a scheme showing the possible hydrogen bonding synthons 293 
involving the secondary amide group of this API with different functional groups such as amide, 294 
carboxylic acid, alcohol, and ester of possible coformers. As a summary, we have analyzed the synthons 295 
exhibited in each of the 11 cocrystals of agomelatine (Figure 13). 296 
Coformers with carboxylic acid as a unique functional group (acetic acid and oxalic acid) as well as 297 
pyruvic acid (which contains an additional carbonyl group) exhibit synthons II and III. Synthon I occurs 298 
in urea and isonicotinamide cocrystals as expected for coformers with amide functional groups. 299 
Cocrystals with ethylene glycol and hydroquinone, which contain alcohols, exhibit synthons V and VI. 300 
However, a new synthon NH···π between the amide and the aromatic group (synthon VII) is observed in 301 
Ago-HQ Form II, instead of synthon VI. Moreover, coformers with two different functional groups such 302 
as glycolic acid (carboxylic acid and alcohol) and methyl-4-hydroxybenzoate (ester and phenol) exhibit 303 
synthons involving both functional groups. In the case of glycolic acid, synthons III and VI are formed, 304 
whereas for methyl-4- hydroxybenzoate, synthons IV and V are observed. Cocrystals are ideally suited 305 
to study competition between different supramolecular heterosynthons. In both cocrystals, synthons are 306 
formed between the best H-bond acceptor (alcohol vs carboxylic acid and ester vs phenol) and the best 307 





4. CONCLUSIONS 313 
 314 
The present study is focused on extending the knowledge about the multicomponent forms of the drug 315 
compound agomelatine. New cocrystals with hydroquinone and several carboxylic acids have been 316 
discovered through an intensive cocrystal screening, and their crystal structures were solved by means of 317 
direct space methods together with single crystal X-ray diffraction data. Our results reveal the existence 318 
of polymorphism at least in two of the new cocrystals showing important differences regarding the type 319 
of intermolecular interactions involved in the crystal, which convert agomelatine in another case to 320 
enrich the list of compounds showing cocrystal polymorphism and at the same time contribute to 321 
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Legends to figures 374 
 375 
Figure 1. Chemical structure of agomelatine. 376 
 377 
Figure 2. DSC of agomelatine−hydroquinone cocrystals. 378 
 379 
Figure 3. Results from powder XRD analysis of Form II of hydroquinone/agomelatine cocrystal: (left) 380 
Final Rietveld plot for the crystal structure refinement. Agreement factors: Rwp = 3.54%, Rp = 2.51%, 381 
(right) Le Bail fit plot. Agreement factors: Rwp = 2.24%, Rp = 1.46%. Each plot shows the 382 
experimental powder XRD profile (red + marks), the calculated powder XRD profile (black solid line), 383 
and the difference profile (blue, lower line). Tick marks indicate peak positions. 384 
 385 
Figure 4. Amide/phenol hydrogen-bond interactions between agomelatine and hydroquinone in Form I 386 
(a) and Form II (b). 387 
 388 
Figure 5. (a) NH···π interaction between the amide and the electron density on the face of the 389 
hydroquinone ring in Form II and (b) CH···π interactions between the naphthalene moieties in Form II. 390 
 391 
Figure 6. Different arrangement of hydroquinone ribbons in Form II (a) and Form I (b). 392 
 393 
Figure 7. Ribbon arrangement of agomelatine pyruvic acid cocrystal. Agomelatine structure has been 394 
truncated. 395 
 396 
Figure 8. Self-assembled units of agomelatine and pyruvic acid. 397 
 398 
Figure 9. Helicoidal topology of Form I (a) and ribbon arrangement of Form II (b) of acetic acid 399 
cocrystals. 400 
 401 
Figure 10. CH···π interactions in Form I (a) and in Form II (b) of acetic acid cocrystals. 402 
 403 
Figure 11. Molecules of agomelatine surrounding oxalic acid in the 2:1 cocrystal. Agomelatine methoxy 404 
groups have been omitted for clarity. 405 
 406 
Figure 12. Ribbon arrangement of agomelatine oxalic acid cocrystal. 407 
 408 
Figure 13. Hydrogen bonding synthons present in agomelatine cocrystals. 409 
410 















































































Table 2. Crystal Data and Structure Refinement Parameters for the Different Forms of Agomelatine 490 
Cocrystals 491 
 492 
 493 
 494 
 495 
 496 
